Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
major depressive disorder
Marketing
Johnson & Johnson launches ‘Generation Fine’ depression project
You’ve heard of Gen Z, but now J&J wants you to be aware of “Generation Fine” as it looks to boost understanding around depression treatment.
Ben Adams
May 8, 2026 9:44am
Psychedelics manufacturer Optimi Health set to go public in US
May 7, 2026 11:48am
Axsome increases Auvelity's peak sales projection to $8B
May 5, 2026 11:48am
Axsome's Auvelity wins FDA expansion for Alzheimer's agitation
May 1, 2026 11:42am
FDA signs off on depression label expansion for J&J's Caplyta
Nov 6, 2025 8:43am
Axsome will begin trial this year in MDD with daytime sleepiness
Apr 1, 2025 4:40pm
